Person-Centred Care in Practice: Perspectives from A Short-Course Regimen for Multi-Drug Resistant Tuberculosis in Karakalpakstan, Uzbekistan
Authors:
Preprint
- 28 April 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction: Person-centred care, an internationally recognised priority, describes the involvement of people in their care and treatment decisions and the consideration of their needs and priorities within service delivery. Clarity is required regarding the feasibility of its implementation within different contexts. The standard multi-drug resistant tuberculosis (MDR-TB) treatment regimen is lengthy, toxic and insufficiently effective. 2019 World Health Organisation guidelines include a shorter (9-11-month) regimen and recommend that people with MDR-TB be involved in the choice of treatment option. We examine the perspectives and experiences of people with MDR-TB and health-care workers (HCW) on treatment choice in an MDR-TB programme in Karakalpakstan, Uzbekistan, run by Médecins Sans Frontières and the Ministry of Health. Methods: A qualitative study comprising 48 interviews with 24 people with MDR-TB and 20 HCW was conducted in June-July 2019. Participants were recruited purposively to include a range of treatment-taking experiences and professional positions. Interview data were analysed thematically using coding to identify emerging patterns, concepts, and categories relating to person-centred care, with Nvivo12. Results: People with MDR-TB were unfamiliar with shared decision-making and felt uncomfortable taking responsibility for their treatment choice. HCW were viewed as having greater knowledge and expertise, and patients trusted HCW to act in their best interests, deferring the choice of appropriate treatment course to them. HCW had concerns about involving people in treatment choices, preferring that doctors made decisions. People with MDR-TB wanted to be involved in discussions about their treatment, and have their preference sought, and were comfortable choosing whether treatment was ambulatory or hospital-based. Participants felt it important that people with MDR-TB had knowledge and understanding about their treatment and disease, to foster their sense of preparedness and ownership for treatment. Involving people in their care was said to motivate sustained treatment-taking, which some felt directly observed treatment (DOT) could undermine. Conclusions: There is a preference for doctors choosing the treatment regimen, linked to shared decision-making unfamiliarity and practitioner-patient knowledge imbalance. Involving people in their care, through discussions, information, and preference-seeking could foster ownership and self-responsibility, supporting sustained engagement with treatment, which DOT may contradict.Keywords
All Related Versions
This publication has 17 references indexed in Scilit:
- Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectivesEuropean Respiratory Review, 2019
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapiesThe Lancet Infectious Diseases, 2018
- Tuberculosis control needs a complete and patient-centric solutionThe Lancet Global Health, 2014
- Responding to medical crises: AIDS treatment, responsibilisation and the logic of choiceAnthropology & Medicine, 2013
- Processes of Self‐Management in Chronic IllnessJournal of Nursing Scholarship, 2012
- Person-Centered Care — Ready for Prime TimeEuropean Journal of Cardiovascular Nursing, 2011
- Person-centredness: Conceptual and historical perspectivesDisability and Rehabilitation, 2007
- Who decides about prostate cancer treatment? A qualitative studyFamily Practice, 2003
- Medical ethics: four principles plus attention to scopeBMJ, 1994
- Illness and the role of the physician: A sociological perspective.American Journal of Orthopsychiatry, 1951